Literature DB >> 20147309

Evolution of virulence when transmission occurs before disease.

Erik E Osnas1, Andrew P Dobson.   

Abstract

Most models of virulence evolution assume that transmission and virulence are constant during an infection. In many viral (HIV and influenza), bacterial (TB) and prion (BSE and CWD) systems, disease-induced mortality occurs long after the host becomes infectious. Therefore, we constructed a model with two infected classes that differ in transmission rate and virulence in order to understand how the evolutionarily stable strategy (ESS) depends on the relative difference in transmission and virulence between classes, on the transition rate between classes and on the recovery rate from the second class. We find that ESS virulence decreases when expressed early in the infection or when transmission occurs late in an infection. When virulence occurred relatively equally in each class and there was disease recovery, ESS virulence increased with increased transition rate. In contrast, ESS virulence first increased and then decreased with transition rate when there was little virulence early in the infection and a rapid recovery rate. This model predicts that ESS virulence is highly dependent on the timing of transmission and pathology after infection; thus, pathogen evolution may either increase or decrease virulence after emergence in a new host.

Entities:  

Mesh:

Year:  2010        PMID: 20147309      PMCID: PMC2936202          DOI: 10.1098/rsbl.2009.1019

Source DB:  PubMed          Journal:  Biol Lett        ISSN: 1744-9561            Impact factor:   3.703


  16 in total

1.  Evolution of virulence in a heterogeneous host population.

Authors:  R R Regoes; M A Nowak; S Bonhoeffer
Journal:  Evolution       Date:  2000-02       Impact factor: 3.694

2.  Parasite transmission modes and the evolution of virulence.

Authors:  T Day
Journal:  Evolution       Date:  2001-12       Impact factor: 3.694

3.  On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations.

Authors:  O Diekmann; J A Heesterbeek; J A Metz
Journal:  J Math Biol       Date:  1990       Impact factor: 2.259

4.  The evolutionary epidemiology of vaccination.

Authors:  Sylvain Gandon; Troy Day
Journal:  J R Soc Interface       Date:  2007-10-22       Impact factor: 4.118

5.  A quantitative test of the relationship between parasite dose and infection probability across different host-parasite combinations.

Authors:  Frida Ben-Ami; Roland R Regoes; Dieter Ebert
Journal:  Proc Biol Sci       Date:  2008-04-07       Impact factor: 5.349

6.  Evolution of parasite virulence when host responses cause disease.

Authors:  Troy Day; Andrea L Graham; Andrew F Read
Journal:  Proc Biol Sci       Date:  2007-11-07       Impact factor: 5.349

7.  Virulence evolution and the trade-off hypothesis: history, current state of affairs and the future.

Authors:  S Alizon; A Hurford; N Mideo; M Van Baalen
Journal:  J Evol Biol       Date:  2009-02       Impact factor: 2.411

8.  Applying population-genetic models in theoretical evolutionary epidemiology.

Authors:  Troy Day; Sylvain Gandon
Journal:  Ecol Lett       Date:  2007-10       Impact factor: 9.492

9.  The evolution of virulence in parasites and pathogens: reconciliation between two competing hypotheses.

Authors:  R E Lenski; R M May
Journal:  J Theor Biol       Date:  1994-08-07       Impact factor: 2.691

10.  Comparative infectiousness of three passerine bird species after experimental inoculation with Mycoplasma gallisepticum.

Authors:  André A Dhondt; Keila V Dhondt; Brynn V McCleery
Journal:  Avian Pathol       Date:  2008-12       Impact factor: 3.378

View more
  2 in total

1.  Assessing the risk of vaccine-driven virulence evolution in SARS-CoV-2.

Authors:  Ian F Miller; C Jessica E Metcalf
Journal:  R Soc Open Sci       Date:  2022-01-05       Impact factor: 2.963

2.  An offer you cannot refuse: down-regulation of immunity in response to a pathogen's retaliation threat.

Authors:  O Restif
Journal:  J Evol Biol       Date:  2013-08-09       Impact factor: 2.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.